$AMRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Amneal Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Amneal Pharmaceuticals, Inc.. Get notifications about new insider transactions in Amneal Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 06 2020 | AMRX | Amneal Pharmaceuti ... | BUCHEN DAVID A | SVP, Chief Legal Of ... | Buy | M | 0.00 | 27,614 | 0 | 28,614 | 1,000 to 28.6 K (+2,761.40 %) |
Dec 17 2019 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | A | 0.00 | 7,522 | 0 | 7,522 | |
Dec 17 2019 | AMRX | Amneal Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | A | 4.76 | 28,506 | 135,689 | 28,506 | |
Dec 17 2019 | AMRX | Amneal Pharmaceuti ... | George Jeffrey P. | Director | Option Exercise | A | 4.76 | 28,506 | 135,689 | 28,506 | |
Dec 17 2019 | AMRX | Amneal Pharmaceuti ... | George Jeffrey P. | Director | Option Exercise | A | 0.00 | 7,522 | 0 | 7,522 | |
Dec 17 2019 | AMRX | Amneal Pharmaceuti ... | Kiely John | Director | Option Exercise | A | 0.00 | 7,522 | 0 | 7,522 | |
Dec 17 2019 | AMRX | Amneal Pharmaceuti ... | Kiely John | Director | Option Exercise | A | 4.76 | 28,506 | 135,689 | 28,506 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | A | 2.75 | 90,498 | 248,870 | 90,498 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | D | 13.50 | 90,498 | 1,221,723 | 0 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | A | 2.75 | 72,661 | 199,818 | 72,661 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | D | 15.01 | 72,661 | 1,090,642 | 0 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | A | 2.75 | 95,525 | 262,694 | 95,525 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | D | 13.50 | 95,525 | 1,289,588 | 0 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | A | 2.75 | 72,661 | 199,818 | 72,661 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | D | 15.01 | 72,661 | 1,090,642 | 0 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Bhadauria Pradeep | SVP, Chief Scientif ... | Option Exercise | A | 2.75 | 153,846 | 423,077 | 153,846 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Bhadauria Pradeep | SVP, Chief Scientif ... | Option Exercise | D | 13.28 | 153,846 | 2,043,075 | 0 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 2.75 | 100,553 | 276,521 | 100,553 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | D | 13.50 | 100,553 | 1,357,466 | 0 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | A | 2.75 | 272,480 | 749,320 | 272,480 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | D | 15.01 | 272,480 | 4,089,925 | 0 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP, Chief Financia ... | Option Exercise | A | 2.75 | 163,666 | 450,082 | 163,666 | |
Nov 14 2019 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP, Chief Financia ... | Option Exercise | D | 12.44 | 163,666 | 2,036,005 | 0 | |
Nov 12 2019 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | C | 0.00 | 12,887,433 | 0 | 17,497,336 | |
Nov 12 2019 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | C | 0.00 | 12,887,433 | 0 | 17,497,336 | |
Nov 12 2019 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Sell | J | 0.00 | 12,887,433 | 0 | 17,497,336 | 30.4 M to 17.5 M (-42.41 %) |
Nov 12 2019 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Sell | J | 0.00 | 12,887,433 | 0 | 17,497,336 | 30.4 M to 17.5 M (-42.41 %) |
Nov 12 2019 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Buy | C | 0.00 | 12,887,433 | 0 | 12,887,433 | 0 to 12.9 M |
Nov 12 2019 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Buy | C | 0.00 | 12,887,433 | 0 | 12,887,433 | 0 to 12.9 M |
Aug 28 2019 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Buy | P | 2.39 | 50,000 | 119,500 | 56,107 | 6.1 K to 56.1 K (+818.73 %) |
Aug 28 2019 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Buy | P | 2.39 | 50,000 | 119,500 | 56,107 | 6.1 K to 56.1 K (+818.73 %) |
Aug 19 2019 | AMRX | Amneal Pharmaceuti ... | Bhadauria Pradeep | SVP, Chief Scientif ... | Buy | P | 2.41 | 30,000 | 72,300 | 37,500 | 7.5 K to 37.5 K (+400.00 %) |
Aug 08 2019 | AMRX | Amneal Pharmaceuti ... | Fosun International Ltd | 10% Owner | Buy | P | 2.91 | 327,000 | 951,570 | 327,000 | 0 to 327 K |
Aug 07 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | P | 2.89 | 66,666 | 192,665 | 95,968 | 29.3 K to 96 K (+227.51 %) |
Aug 07 2019 | AMRX | Amneal Pharmaceuti ... | Fosun International Ltd | 10% Owner | Buy | P | 3.04 | 1,642,300 | 4,992,592 | 1,642,300 | 0 to 1.6 M |
Aug 06 2019 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Option Exercise | A | 0.00 | 27,923 | 0 | 27,923 | |
Aug 06 2019 | AMRX | Amneal Pharmaceuti ... | MEISTER PAUL M | Director | Option Exercise | A | 3.25 | 115,156 | 374,257 | 115,156 | |
May 16 2019 | AMRX | Amneal Pharmaceuti ... | Bhadauria Pradeep | SVP, Chief Scientif ... | Buy | P | 8.48 | 7,000 | 59,360 | 7,500 | 500 to 7.5 K (+1,400.00 %) |
May 13 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | P | 9.46 | 19,000 | 179,740 | 29,302 | 10.3 K to 29.3 K (+184.43 %) |
May 13 2019 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Buy | P | 9.88 | 15,000 | 148,200 | 205,590 | 190.6 K to 205.6 K (+7.87 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Option Exercise | M | 0.00 | 4,441 | 0 | 13,325 | |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Payment of Exercise | F | 13.44 | 2,228 | 29,944 | 190,590 | 192.8 K to 190.6 K (-1.16 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | SVP, Specialty Comm ... | Buy | M | 0.00 | 4,441 | 0 | 192,818 | 188.4 K to 192.8 K (+2.36 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Option Exercise | M | 0.00 | 16,655 | 0 | 49,967 | |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Payment of Exercise | F | 13.44 | 8,353 | 112,264 | 10,302 | 18.7 K to 10.3 K (-44.78 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Exec VP, Comm Optns | Buy | M | 0.00 | 16,655 | 0 | 18,655 | 2 K to 18.7 K (+832.75 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Executive Chairman | Option Exercise | M | 0.00 | 24,983 | 0 | 74,950 | |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Executive Chairman | Payment of Exercise | F | 13.44 | 12,529 | 168,390 | 29,454 | 42 K to 29.5 K (-29.84 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Executive Chairman | Buy | M | 0.00 | 24,983 | 0 | 41,983 | 17 K to 42 K (+146.96 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | Stewart Robert A | President and CEO | Option Exercise | M | 0.00 | 83,277 | 0 | 249,834 | |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | Stewart Robert A | President and CEO | Payment of Exercise | F | 13.44 | 21,609 | 290,425 | 78,668 | 100.3 K to 78.7 K (-21.55 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | Stewart Robert A | President and CEO | Buy | M | 0.00 | 83,277 | 0 | 100,277 | 17 K to 100.3 K (+489.86 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | M | 0.00 | 4,441 | 0 | 13,325 | |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Payment of Exercise | F | 13.44 | 1,366 | 18,359 | 169,111 | 170.5 K to 169.1 K (-0.80 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Buy | M | 0.00 | 4,441 | 0 | 170,477 | 166 K to 170.5 K (+2.67 %) |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | BUCHI J KEVIN | Director | Buy | M | 0.00 | 6,107 | 0 | 17,408 | 11.3 K to 17.4 K (+54.04 %) |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Buy | M | 0.00 | 6,107 | 0 | 6,107 | 0 to 6.1 K |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Director | Buy | M | 0.00 | 6,107 | 0 | 6,107 | 0 to 6.1 K |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Rama Dharmendra | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Rama Dharmendra | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Rama Dharmendra | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Rama Dharmendra | Director | Buy | M | 0.00 | 6,107 | 0 | 6,107 | 0 to 6.1 K |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Buy | M | 0.00 | 6,107 | 0 | 6,107 | 0 to 6.1 K |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | BURR ROBERT L | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | BURR ROBERT L | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | BURR ROBERT L | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | BURR ROBERT L | Director | Buy | M | 0.00 | 6,107 | 0 | 96,582 | 90.5 K to 96.6 K (+6.75 %) |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Vergis Janet S. | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Vergis Janet S. | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Vergis Janet S. | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Vergis Janet S. | Director | Buy | M | 0.00 | 6,107 | 0 | 18,257 | 12.2 K to 18.3 K (+50.26 %) |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | TERRERI PETER R | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | TERRERI PETER R | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | TERRERI PETER R | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | TERRERI PETER R | Director | Buy | M | 0.00 | 6,107 | 0 | 76,299 | 70.2 K to 76.3 K (+8.70 %) |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Greene Jean Selden | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Greene Jean Selden | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Greene Jean Selden | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Greene Jean Selden | Director | Buy | M | 0.00 | 6,107 | 0 | 6,107 | 0 to 6.1 K |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | Director | Buy | M | 0.00 | 6,107 | 0 | 6,107 | 0 to 6.1 K |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Option Exercise | M | 0.00 | 6,107 | 0 | 0 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Option Exercise | A | 0.00 | 6,459 | 0 | 6,459 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Option Exercise | A | 14.05 | 28,044 | 394,018 | 28,044 | |
May 08 2019 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Buy | M | 0.00 | 6,107 | 0 | 6,107 | 0 to 6.1 K |
Mar 12 2019 | AMRX | Amneal Pharmaceuti ... | Stewart Robert A | President and CEO | Buy | P | 11.92 | 17,000 | 202,640 | 17,000 | 0 to 17 K |
Mar 12 2019 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Executive Chairman | Buy | P | 11.97 | 17,000 | 203,490 | 17,000 | 0 to 17 K |
Mar 07 2019 | AMRX | Amneal Pharmaceuti ... | TERRERI PETER R | Director | Option Exercise | M | 6.55 | 45,000 | 294,750 | 0 | |
Mar 07 2019 | AMRX | Amneal Pharmaceuti ... | TERRERI PETER R | Director | Buy | M | 6.55 | 45,000 | 294,750 | 70,192 | 25.2 K to 70.2 K (+178.63 %) |
Mar 07 2019 | AMRX | Amneal Pharmaceuti ... | TERRERI PETER R | Director | Sell | S | 12.39 | 23,345 | 289,245 | 25,192 | 48.5 K to 25.2 K (-48.10 %) |
Jan 24 2019 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP, Chief Financia ... | Option Exercise | A | 0.00 | 80,386 | 0 | 80,386 | |
Jan 24 2019 | AMRX | Amneal Pharmaceuti ... | Branning Todd P. | SVP, Chief Financia ... | Option Exercise | A | 12.44 | 163,666 | 2,036,005 | 163,666 | |
Jan 16 2019 | AMRX | Amneal Pharmaceuti ... | BURR ROBERT L | Director | Option Exercise | M | 6.55 | 30,000 | 196,500 | 0 | |
Jan 16 2019 | AMRX | Amneal Pharmaceuti ... | BURR ROBERT L | Director | Buy | M | 6.55 | 30,000 | 196,500 | 90,475 | 60.5 K to 90.5 K (+49.61 %) |
Jan 07 2019 | AMRX | Amneal Pharmaceuti ... | BUCHEN DAVID A | SVP, Chief Legal Of ... | Option Exercise | A | 0.00 | 110,457 | 0 | 110,457 | |
Jan 07 2019 | AMRX | Amneal Pharmaceuti ... | BUCHEN DAVID A | SVP, Chief Legal Of ... | Option Exercise | A | 13.58 | 227,273 | 3,086,367 | 227,273 | |
Aug 23 2018 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Sell | S | 23.46 | 50,000 | 1,173,000 | 166,036 | 216 K to 166 K (-23.14 %) |
Aug 23 2018 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Sell | S | 23.46 | 50,000 | 1,173,000 | 166,036 | 216 K to 166 K (-23.14 %) |
Aug 23 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Sell | S | 23.65 | 11,698 | 276,658 | 82,986 | 94.7 K to 83 K (-12.35 %) |
Aug 23 2018 | AMRX | Amneal Pharmaceuti ... | Reasons Bryan M. | CFO | Sell | S | 23.65 | 11,698 | 276,658 | 82,986 | 94.7 K to 83 K (-12.35 %) |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | J | 0.00 | 30,384,769 | 0 | 30,384,769 | |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Buy | J | 0.00 | 30,384,769 | 0 | 30,384,769 | 0 to 30.4 M |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Buy | J | 0.00 | 216,036 | 0 | 216,036 | 0 to 216 K |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | Hirt Sheldon | SVP, GC & Corp. Sec ... | Buy | J | 0.00 | 34,993 | 0 | 34,993 | 0 to 35 K |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Director | Option Exercise | J | 0.00 | 24,753,252 | 0 | 24,753,252 | |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Director | Buy | J | 0.00 | 24,753,252 | 0 | 24,753,252 | 0 to 24.8 M |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | Director | Option Exercise | J | 0.00 | 21,269,420 | 0 | 21,269,420 | |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | Director | Buy | J | 0.00 | 21,269,420 | 0 | 21,269,420 | 0 to 21.3 M |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | APHC Holdings, LLC | 10% Owner | Option Exercise | J | 0.00 | 171,260,707 | 0 | 0 | |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | APHC Holdings, LLC | 10% Owner | Sell | J | 0.00 | 171,260,707 | 0 | 0 | 171.3 M to 0 (-100.00 %) |
Jul 09 2018 | AMRX | Amneal Pharmaceuti ... | APHC Holdings, LLC | 10% Owner | Sell | J | 0.00 | 6,886,140 | 0 | 0 | 6.9 M to 0 (-100.00 %) |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Greene Jean Selden | Director | Option Exercise | A | 0.00 | 6,107 | 0 | 6,107 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Greene Jean Selden | Director | Option Exercise | A | 15.01 | 24,977 | 374,905 | 24,977 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Rama Dharmendra | Director | Option Exercise | A | 0.00 | 6,107 | 0 | 6,107 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Rama Dharmendra | Director | Option Exercise | A | 15.01 | 24,977 | 374,905 | 24,977 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | A | 0.00 | 6,107 | 0 | 6,107 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Gautam | Director | Option Exercise | A | 15.01 | 24,977 | 374,905 | 24,977 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | Director | Option Exercise | A | 0.00 | 6,107 | 0 | 6,107 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | Director | Option Exercise | A | 15.01 | 24,977 | 374,905 | 24,977 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Option Exercise | A | 0.00 | 6,107 | 0 | 6,107 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Nark Ted C | Director | Option Exercise | A | 15.01 | 24,977 | 374,905 | 24,977 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Option Exercise | A | 0.00 | 6,107 | 0 | 6,107 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Alva Emily Peterson | Director | Option Exercise | A | 15.01 | 24,977 | 374,905 | 24,977 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | A | 0.00 | 17,766 | 0 | 17,766 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | SVP, Chief HR Offic ... | Option Exercise | A | 15.01 | 72,661 | 1,090,642 | 72,661 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Director | Option Exercise | A | 0.00 | 6,107 | 0 | 6,107 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Director | Option Exercise | A | 15.01 | 24,977 | 374,905 | 24,977 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Stewart Robert A | President & CEO | Option Exercise | A | 0.00 | 333,111 | 0 | 333,111 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Stewart Robert A | President & CEO | Option Exercise | A | 15.01 | 681,199 | 10,224,797 | 681,199 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Hirt Sheldon | SVP, GC & Corp Sec | Option Exercise | A | 0.00 | 17,766 | 0 | 17,766 | |
May 09 2018 | AMRX | Amneal Pharmaceuti ... | Hirt Sheldon | SVP, GC & Corp Sec | Option Exercise | A | 15.01 | 72,661 | 1,090,642 | 72,661 | |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | APHC Holdings, LLC | 10% Owner | Option Exercise | C | 0.00 | 12,328,767 | 0 | 171,260,707 | |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | APHC Holdings, LLC | 10% Owner | Option Exercise | C | 0.00 | 41,406,689 | 0 | 183,589,474 | |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | APHC Holdings, LLC | 10% Owner | Sell | J | 0.00 | 53,735,465 | 0 | 171,260,707 | 225 M to 171.3 M (-23.88 %) |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | APHC Holdings, LLC | 10% Owner | Sell | S | 18.25 | 12,328,767 | 224,999,998 | 0 | 12.3 M to 0 (-100.00 %) |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | APHC Holdings, LLC | 10% Owner | Sell | S | 18.25 | 34,520,549 | 630,000,019 | 6,886,140 | 41.4 M to 6.9 M (-83.37 %) |